Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01765764 · ClinicalTrials.gov registry record · Phase 3
Bimatoprost for the Treatment of Eyebrow Hypotrichosis
A Phase 3 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 3
- Development phase
- 357
- Enrollment target
NCT01765764: Completed Phase 3 study, sponsored by Allergan.
NCT01765764 is a Phase 3 study that has completed, run by Allergan. The registered enrollment target is 357 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (54% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01765764, a Phase 3 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 357 participants
- Enrollment target
Study Summary
This study will evaluate the safety and efficacy of bimatoprost solution compared with vehicle in the treatment of eyebrow hypotrichosis (inadequate eyebrows).
Primary Outcome
The physician evaluated eyebrow fullness using the 4-point GEBA Scale where: 1=very sparse, 2=sparse, 3=full and 4=very full. The percentage of participants with at least a 1-grade increase from Baseline is reported.
Interventions
- DRUG bimatoprost solution
- DRUG Vehicle to bimatoprost solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 357 participants |
| Start Date | 2013-03-13 |
| Est. Completion | 2014-02-11 |
| Phase | Phase 3 |
What the finished NCT01765764 record still lists
NCT01765764 is an interventional study that assigns participants to a tested intervention. The registered 357 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (54% lower).
The record links to 0 conditions, and to 2 interventions - of which bimatoprost solution is the first listed.
NCT01765764 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01765764 about?
NCT01765764 is a clinical study titled "Bimatoprost for the Treatment of Eyebrow Hypotrichosis". This study will evaluate the safety and efficacy of bimatoprost solution compared with vehicle in the treatment of eyebrow hypotrichosis (inadequate eyebrows).
What is the current status of trial NCT01765764?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 357 participants. The study started on 2013-03-13. Estimated completion is 2014-02-11.
What interventions are being tested in trial NCT01765764?
The interventions under investigation include: bimatoprost solution (DRUG), Vehicle to bimatoprost solution (DRUG).
Who is sponsoring clinical trial NCT01765764?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01765764's enrollment target sits among peer trials
357 1023rd of 2000 higher than 977 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06062888 · 357 participants · Phase 2
FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial
- NCT06109766 · 357 participants · NA
Delivering Evidence-Based Parenting Services to Families in Child Welfare Using Telehealth
- NCT06231342 · 357 participants · NA
Endotracheal Tube (ETT) 180: Stylet-loaded Endotracheal Tube Rotation Before Insertion
- NCT06533826 · 357 participants · Phase 2
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI